InsiderClue
Stocks · Health care · Services-Medical Laboratories

Quest Diagnostics

DGX Clue Score42
United States Fiscal year ends December CIK 0001022079 Results filed 22 Oct 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

50
Insider
Date
Role
Action
Shares
Price
Amount
Gary M Pfeiffer
26 Oct 2026
Director
Sold on a plan
1,203
$243.00
$292.33K
J. E. Davis
1 Sep 2026
CEO and President
Sold on a plan
10,000
$242.72
$2.43M
Mark E Delaney
28 Jul 2026
SVP & Chief Commercial Officer
Sold on a plan
1,600
$235.18
$376.29K
J. E. Davis
1 Jun 2026
CEO and President
Sold on a plan
10,000
$194.14
$1.94M
Patrick Plewman
5 Mar 2026
SVP for Diagnostic Services
Sold on a plan
2,855
$206.21
$588.73K
Michael E Prevoznik
5 Mar 2026
SVP & General Counsel
Sold on a plan
3,878
$206.21
$799.68K
Catherine T. Doherty
5 Mar 2026
EVP, Regional Businesses
Sold on a plan
5,558
$206.21
$1.15M
Patrick Plewman
3 Mar 2026
SVP for Diagnostic Services
Sold on a plan
410
$207.73
$85.17K
Michael E Prevoznik
3 Mar 2026
SVP & General Counsel
Sold on a plan
526
$207.73
$109.27K
Catherine T. Doherty
3 Mar 2026
EVP, Regional Businesses
Sold on a plan
632
$207.73
$131.29K
J. E. Davis
2 Mar 2026
CEO and President
Sold on a plan
10,000
$212.52
$2.13M
Catherine T. Doherty
19 Feb 2026
EVP, Regional Businesses
Sold on a plan
1,433
$204.83
$293.52K
Michael E Prevoznik
19 Feb 2026
SVP & General Counsel
Sold on a plan
1,111
$204.83
$227.57K
Patrick Plewman
19 Feb 2026
SVP for Diagnostic Services
Sold on a plan
958
$204.83
$196.23K
Patrick Plewman
21 Aug 2025
SVP for Diagnostic Services
Sold on a plan
1,975
$185.00
$365.38K
Patrick Plewman
15 Aug 2025
SVP for Diagnostic Services
Sold on a plan
1,975
$180.00
$355.50K
Karthik Kuppusamy
31 Jul 2025
SVP, Clinical Solutions
Sold on a plan
2,210
$170.00
$375.70K
Mark E Delaney
13 May 2025
SVP & Chief Commercial Officer
Sold on a plan
874
$175.31
$153.22K
Mark E Delaney
12 May 2025
SVP & Chief Commercial Officer
Sold on a plan
874
$175.72
$153.58K
Karthik Kuppusamy
2 Apr 2025
SVP, Clinical Solutions
Sold on a plan
2,555
$170.00
$434.35K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
453
$169.63
$76.84K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
902
$168.79
$152.25K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
1,493
$167.88
$250.64K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
267
$169.60
$45.28K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
584
$168.70
$98.52K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
750
$167.86
$125.90K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
2,493
$169.57
$422.74K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
5,900
$168.66
$995.12K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
6,950
$167.86
$1.17M
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
2,764
$169.56
$468.66K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
4,905
$168.72
$827.56K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
7,249
$167.86
$1.22M
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
704
$169.63
$119.42K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
1,411
$168.76
$238.11K
J. E. Davis
2 Apr 2025
CEO and President
Sold on a plan
2,366
$168.03
$397.55K
Michael E Prevoznik
17 Mar 2025
SVP & General Counsel
Sold on a plan
4,643
$170.00
$789.31K
Catherine T. Doherty
5 Mar 2025
EVP, Regional Businesses
Sold on a plan
5,370
$174.13
$935.08K
Michael E Prevoznik
4 Mar 2025
SVP & General Counsel
Sold on a plan
592
$175.79
$104.07K
Catherine T. Doherty
4 Mar 2025
EVP, Regional Businesses
Sold on a plan
716
$175.79
$125.87K
Catherine T. Doherty
27 Feb 2025
EVP, Regional Businesses
Sold on a plan
824
$172.61
$142.23K
Michael E Prevoznik
27 Feb 2025
SVP & General Counsel
Sold on a plan
528
$172.61
$91.14K
Catherine T. Doherty
20 Feb 2025
EVP, Regional Businesses
Sold on a plan
899
$170.99
$153.72K
Michael E Prevoznik
20 Feb 2025
SVP & General Counsel
Sold on a plan
604
$170.99
$103.28K
Catherine T. Doherty
19 Feb 2025
EVP, Regional Businesses
Sold on a plan
535
$169.71
$90.79K
Karthik Kuppusamy
29 Apr 2024
SVP, Clinical Solutions
Sold on a plan
1,760
$140.00
$246.40K
Michael E Prevoznik
29 Feb 2024
SVP & General Counsel
Sold on a plan
5,611
$125.88
$706.31K
Catherine T. Doherty
29 Feb 2024
EVP, Regional Businesses
Sold on a plan
1,187
$125.88
$149.42K
Catherine T. Doherty
28 Feb 2024
EVP, Regional Businesses
Sold on a plan
5,557
$126.57
$703.35K
Catherine T. Doherty
22 Feb 2024
EVP, Regional Businesses
Sold on a plan
821
$126.14
$103.56K
Michael E Prevoznik
22 Feb 2024
SVP & General Counsel
Sold on a plan
661
$126.14
$83.38K
Showing 250 of 295 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 656
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 50
Sales straight out of an exercise 166
Sales at will 79
Transactions with no price 0
Shares from compensation/vesting 5,989,127
Sales filed before the plan box existed 69
History held since 3 Oct 2006